Evidence map›Paper›PMID 33276612›Full record

ReviewDiagnostics (Basel, Switzerland)2020

Rethinking Elective Cataract Surgery Diagnostics, Assessments, and Tools after the COVID-19 Pandemic Experience and Beyond: Insights from the EUROCOVCAT Group.

Daniele Tognetto, Antoine P Brézin, Arthur B Cummings, Boris E Malyugin, Ozlem Evren Kemer, Isabel Prieto, Robert Rejdak, Miguel A Teus, Riikka Törnblom, Mario D Toro and 3 more

Abstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Improving the patient decision-making experience for cataract surgery during the COVID-19 era.Canadian journal of ophthalmology. Journal canadien d'ophtalmologie · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Psychological Impact of Cancellation of Elective Surgeries for Ophthalmic Patients during COVID-19 Pandemic.International journal of environmental research and public health · 2022
    Article
  9. Observational
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Daniele TognettoEye Clinic, Department of Medicine, Surgery and Health Sciences, University of Trieste, 34134 Trieste, Italy.
Antoine P BrézinUniversité de Paris, Hôpital Cochin, 75014 Paris, France.ORCID 0000-0001-8461-3119
Arthur B CummingsWellington Eye Clinic, D18 T8P3 Dublin, Ireland.
Boris E MalyuginS. Fyodorov Eye Microsurgery Federal State Institution, Russian Federation, 127486 Moscow, Russia.ORCID 0000-0001-5666-3493
Ozlem Evren KemerUniversity of Health Sciences, Ankara City Hospital, 06800 Ankara, Turkey.ORCID 0000-0001-9480-8470
Isabel PrietoDepartment of Ophthalmology, Fernando Fonseca Hospital, 2720-276 Amadora, Portugal.
Robert RejdakDepartment of General Ophthalmology, Medical University of Lublin, 20-079 Lublin, Poland.ORCID 0000-0003-3321-2723
Miguel A TeusDepartment of Ophthalmology, University of Alcalá, 28802 Madrid, Spain.ORCID 0000-0002-3835-9882
Riikka TörnblomDepartment of Ophthalmology, TYKS Hospital, 20521 Turku, Finland.
Mario D ToroDepartment of General Ophthalmology, Medical University of Lublin, 20-079 Lublin, Poland.ORCID 0000-0001-7152-2613
Alex L VinciguerraEye Clinic, Department of Medicine, Surgery and Health Sciences, University of Trieste, 34134 Trieste, Italy.
Rosa GiglioEye Clinic, Department of Medicine, Surgery and Health Sciences, University of Trieste, 34134 Trieste, Italy.ORCID 0000-0001-9755-0786
Chiara De GiacintoEye Clinic, Department of Medicine, Surgery and Health Sciences, University of Trieste, 34134 Trieste, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The progressive deterioration of the visual function in patients on waiting lists for cataract surgery has a negative impact on their quality of life, especially in the elderly population. Patient waiting times for cataract surgeries in many healthcare settings have increased recently due to the prolonged stop or slowdown of elective cataract surgery as a result of coronavirus disease 19 (COVID-19). The aim of this review is to highlight the impact of such a "de-prioritization" of cataract surgery and to summarize some critical issues and useful hints on how to reorganize cataract pathways, with a special focus on perioperative diagnostic tools during the recovery phase and beyond. The experiences of a group of surgeons originating from nine different countries, named the European COVID-19 Cataract Group (EUROCOVCAT), have been combined with the literature and recommendations from scientific ophthalmic societies and healthcare institutions. Key considerations for elective cataract surgery should include the reduction of the number of unnecessary visits and examinations, adoption of precautionary measures, and implementation of telemedicine instruments. New strategies should be adopted to provide an adequate level of assistance and to guarantee safety conditions. Flexibility will be the watchword and regular updates would be necessary following scientific insights and the development of the pandemic.

Indexed as

cataract surgeryCOVID-19 outbreakphacoemulsification

Identifiers

PMID33276612
PMCPMC7761628

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.